Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Proposes To Cover More Telehealth, And Address Imaging, Lab Pay Matters

Executive Summary

The US Medicare agency has proposed several changes to the status quo in its planned 2019 Medicare physician fee schedule and clinical laboratory fee schedule that will impact reimbursements for telehealth services, the advanced imaging industry and clinical laboratories.

You may also be interested in...



Upcoming CMS Appropriate Use Criteria Policy For Ordering Advanced Imaging Raises Concerns

Medical specialty groups are raising concerns about a planned policy change in 2020 by the US Medicare agency to require use of clinical decision support mechanism (CDSM) software to ensure physicians review appropriate use criteria before ordering advanced imaging scans.

Medicare Telehealth Models Would Be Tested Under House Bill

A new US House bill would require the Centers for Medicare and Medicaid Services’ innovation center to test some telehealth service models to enhance access to care for beneficiaries in remote areas of the country.

Remote Monitoring, Virtual Care Get More Support In Medicare Rules

Remote patient monitoring costs can be reported by home health agencies as allowable Medicare costs starting in 2020 under a new regulation. And, in a separate rule, Medicare has established new reimbursement categories for "virtual" health care.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel